亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Prophylaxis or Treatment of Feline Coronavirus Infection

详细技术说明
This technology describes a novel method that may offer a cure forfeline infectious peritonitis virus (FIPV).
*Abstract

Feline coronavirus (FCoV) infection in >90% of infected cats results in only mild and often inapparent enteritis. This form of FCoV is referred to as feline enteric coronavirus (FECV). However, in a small number of animals, FECV mutates into a form that confers it with the ability to infect macrophages and monocytes. It is this mutated form of the virus, called feline infectious peritonitis virus (FIPV) that leads to feline infectious peritonitis (FIP) - a lethal infection in cats and the most feared disease in catteries, for which there is no effective treatment.

 

Cornell researchers have developed a novel treatment paradigm for FIP and suppression of FCoV infection more generally. Specifically, differential cleavage by different cysteine proteases of the viral spike protein involved in viral entry was shown to be a critical factor in explaining the different pathogenic properties of FECV and FIPV. As such, FIPV treatment and suppression of FCoV infections more generally may be possible using cysteine protease inhibitors that target specific cysteine proteases.

 

Potential Applications

Treatment of FCoV and FIPV infection in cats

 

For more details, you arewelcome to download the technology brief.

*Licensing
Phillip Owhpo62@cornell.edu607-254-4508
其他
  • U.S.patent number 9,044,486.
  • ReganAD & al. (2008). Differential role for low pH and cathepsin-mediatedcleavage of the viral spike protein during entry of serotype II felinecoronaviruses. Vet Microbiol. Dec10;132(3-4):235-48. doi: 10.1016/j.vetmic.2008.05.019.

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备